Rinsho Ketsueki
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
A Case of T Cell Lymphoma Arising from the Nasal Septum with a Long Survival Time by the Combined Therapy with Irradiation and Immunopotenciator
Chihiro SHIMAZAKI, Tetsuo NAKATA, Akira NISHIO, Harue HARUYAMA, Akito KATSUKI, Masao NAKAGAWA, Kiyoaki SUGISHIMA, Hamao IJICHI, Takuji ISEMURA
Author information
JOURNAL RESTRICTED ACCESS

1980 Volume 21 Issue 12 Pages 1892-1897

Details
Abstract
This paper presents a case of T-cell lymphoma with a long survival achieved by radiation and immunochemotherapy.
A 46 year old male, a non-native of Kyushu district, was admitted to our service for the further evaluation and treatment of subcutaneous tumor of r. shoulder and l. arm on January 1979. Two years prior to admission the patient was diagnosed as malignant lymphoma from the histological findings of dissected nasal septal tumor, which was treated by irradiation therapy alone. A tumor of the r. inguinal region was extripated for further evaluation and was diagnosed as poorly differentiated malignant lymphoma. These tumor cells formed rosette with sheep erythrocytes. Bone marrow aspiration revealed hypocellularity without tumor cells and he was treated by prednisolone alone with poor response and additional local administration of OK-432 was started into the tumor which became soften in consistency and decreased in size. Positive direct Coomb's test and antiplatelet antibody were detected in short time of thrombocytopenia, and the increased administration of prednisolone improved the platelet counts. In spite of immunochemotherapy including prednisolone, Bleomycin, oil-Bleo and OK-432, the tumor size was increased and symptom was aggravated and expired on March 1979 due to shock induced by oil-Bleo injection.
Through the clinical evaluation of this patient, it is emphasized that 28 months long survival was achieved responding to the treatment with irradiation and local OK-432 administration. This case of T-cell lymphoma suggested the effectiveness of the combined therapy with irradiation and immunopotenciator.
Content from these authors
© 1980 The Japanese Society of Clinical Hematology
Previous article Next article
feedback
Top